BioCentury
ARTICLE | Clinical News

Tradjenta: Phase III data

July 15, 2013 7:00 AM UTC

A double-blind, international Phase III trial of 235 Type II diabetes with moderate to severe renal impairment, defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m2, showed ...